Chitosan/Alginate Nanoparticles for the Enhanced Oral Antithrombotic Activity of Clam Heparinoid from the Clam Coelomactra antiquata

Abstract

Chitosan/alginate nanoparticles (DG1-NPs and DG1/Cur-NPs) aiming to enhance the oral antithrombotic activity of clam heparinoid DG1 were prepared by ionotropic pre-gelation. The influence of parameters, such as the concentration of sodium alginate (SA), chitosan (CTS), CaCl2, clam heparinoid DG1, and curcumin (Cur), on the characteristics of the nanoparticles, were investigated. Results indicate that chitosan and alginate can be used as polymer matrices to encapsulate DG1, and nanoparticle characteristics depend on the preparation parameters. Nano-particles should be prepared using 0.6 mg/mL SA, 0.33 mg/mL CaCl2, 0.6 mg/mL CTS, 7.2 mg/mL DG1, and 0.24 mg/mL Cur under vigorous stirring to produce DG1-NPS and DG1/Cur-NPS with small size, high encapsulation efficiency, high loading capacity, and negative zeta potential from approximately −20 to 30 mV. Data from scanning electron microscopy, Fourier-transform infrared spectrometry, and differential scanning calorimetry analyses showed no chemical reaction between DG1, Cur, and the polymers; only physical mixing. Moreover, the drug was loaded in the amorphous phase within the nanoparticle matrix. In the acute pulmonary embolism murine model, DG1-NPs enhanced the oral antithrombotic activity of DG1, but DG1/Cur-NPs did not exhibit higher antithrombotic activity than DG1-NPs. Therefore, the chitosan/alginate nanoparticles enhanced the oral antithrombotic activity of DG1, but curcumin did not further enhance this effect.

Regulatory Effects of Curcumin on Platelets: An Update and Future Directions

“…Curcumin has been found to be an agonist of A 2A receptor that activates the PKA/cAMP/AC pathway in thrombocytes. Blockade of A 2A receptor resulted in the inhibition of PKA, which denotes that this receptor is the key player the involvement of curcumin-induced activation of PKA in thrombocytes [ 150 ].…”

Broad-spectrum ginsentides are principal bioactives in unraveling the cure-all effects of ginseng

“…The anti-thrombotic effects of ginsentide TP1 was studied using an in vivo acute thrombotic mouse model 34 conducted by Thousand Dimensions (Beijing) Science and Technology Co., Ltd. (Beijing, China) as a service contract. Male Institute of Cancer Research (ICR) mice (23–25 g body weight) were purchased from Beijing HFK Bioscience Co., Ltd. (Beijing, China).…”

Shrimp Waste Upcycling: Unveiling the Potential of Polysaccharides, Proteins, Carotenoids, and Fatty Acids with Emphasis on Extraction Techniques and Bioactive Properties

“…The release of drugs from chitosan microspheres is dependent on factors such as the molecular weight of chitosan, chitosan concentration, drug content, and crosslinking density. Chitosan microspheres have been employed to incorporate various therapeutic agents, including anticancer [152,156], anti-inflammatory [157], antibiotic [158,159], antithrombotic [160], and antidiabetic [161] agents, among others, to achieve controlled release.…”